DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Tfayli H, Ulnach JW, Lee S. et al.
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight
adolescents with polycystic ovary syndrome: Comparison of metabolic, hormonal,
and cardiovascular risk factors.
J Clin Endocrinol Metab 2011;
96: 1311-1319
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.